CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Niusule Bio Pharmaceutical Corporation is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Niusule Bio Pharmaceutical Corporation
2533 N Carson St Ste 1-Z
Phone: (775) 887-4880p:775 887-4880 CARSON CITY, NV  89706-0242  United States Fax: (775) 525-2898f:775 525-2898
This company ceased filing statements with the SEC on 12/1/2010.
This company is no longer actively traded on any major stock exchange.
Business Summary
Niusule Bio-pharmaceutical Corp., formerly Niusule Biotech Corp., focuses on selling United States health food to Chinese market. On July 24, 2009, the Company began to sell PlantFusion protein in Hangzhou Tower. On August 25, 2009, the Company began to sell PlantFusion protein in Hangzhou Jiebai Group Co., Ltd and Hangzhou Stadium. On September 16, 2009, it began to sell Gummy Bears in Hangzhou Tower and Hangzhou Jiebai Group Co., Ltd. On March 4, 2009, the Company formed a wholly owned subsidiary, Niusule Bioengineering (Hangzhou) Co. Ltd.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/20106/30/2009YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Executive Officer QinghuaHu 45 11/6/2009 4/8/2008
Part Time Chief Technology Officer ShanjingYao 56 4/8/2008 4/8/2008
Chief Marketing Officer HuifengDong 44 4/1/2010 4/1/2010
4 additional Officers and Directors records available in full report.

Business Names
Business Name
NIUS
Niusule Biotech Corp
Niusule Biotech Corp.
Zhejiang Baitai Bioengineering Corp.

General Information
Stock Exchange: OTC
Federal Tax Id: 262401986
Fax Number: (775) 525-2898


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023